Sort
172,184 grants matching “inflammation”
Dupilumab in the Treatment of Pediatric Alopecia Areata
$1,419,216Emma Guttman · Icahn School Of Medicine At Mount Sinai · U01 · FY2024 · AI
1/1: ARREST RESPIRATORY FAILURE DUE TO PNEUMONIA (ARREST PNEUMONIA)
$1,419,180Joseph Eric Levitt · Stanford University · UG3 · FY2019 · HL
Airway inflammation and airway remodeling
$1,418,900David H Broide · University Of California, San Diego · U19 · FY2017 · AI
SIGNALING PATHWAYS IN CONTROL OF GROWTH AND DEVELOPMENT
$1,418,844Alan R Kimmel · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2016 · DK
Mechanism Of Action And Functions Of The Gli-related Proteins Glis 1-3
$1,418,801Anton M Jetten · National Institute Of Environmental Health Sciences · ZIA · FY2011 · ES
Retinal Circuit Development & Genetics
$1,418,568Tudor Badea · National Eye Institute · ZIA · FY2020 · EY
RP3: Targeting ATG gene-dependent immunity for novel anti-infective therapeutics
$1,418,421Seungmin Hwang · Ut Southwestern Medical Center · U19 · FY2020 · AI
TRANSPIRE: A Prospective Cohort Study of Lung Injury After Hematopoietic Stem Cell Transplant in Children.
$1,418,412Stella Margaret Davies · Cincinnati Childrens Hosp Med Ctr · R01 · FY2024 · HL
Sphingomab Mitigates the Multiple Pathologies of Age-Related Macular Degeneration
$1,418,276Roger Allen Sabbadini · Lpath Therapeutics, Inc. · R44 · FY2008 · EY
Evaluation and treatment of drug-resistant epilepsy
$1,418,206William Theodore · National Institute Of Neurological Disorders And Stroke · ZIA · FY2017 · NS
Mechanism of action of omega-3 fatty acids in brain injury
$1,418,175Nicolas Guillermo Bazan · Lsu Health Sciences Center · RC2 · FY2009 · AT
Biomarkers of Atopy Beginning Early (BABE)
$1,418,167Kirsi Jarvinen-Seppo · University Of Rochester · U19 · FY2024 · AI
Novel compounds for the treatment of systemic sclerosis-associated interstitial lung disease
$1,417,658Scott Scarneo · Eydis Bio, Inc. · R44 · FY2025 · HL
Impact of Stretching on Tumor growth and Metastasis
$1,417,327Lisbeth Berrueta Carrillo · National Institute Of Dental & Craniofacial Research · ZIA · FY2023 · DE
Efficacy and Safety of Beta-adrenoceptor Inverse Agonist, Nadolol in Mild Asthma
$1,417,316Nicola A Hanania · Baylor College Of Medicine · U01 · FY2011 · AI
Treatment of Acid Ceramidase Deficiency
$1,417,065Sharie Haugabook · National Center For Advancing Translational Sciences · ZIA · FY2016 · TR
NATIONAL NEUROLOGICAL AIDS BANK
$1,416,980Elyse J Singer · University Of California Los Angeles · U24 · FY2022 · MH
Preventing Pregnancy Malaria: Maternal-Infant Outcomes
$1,416,860Patrick E Duffy · Seattle Biomedical Research Institute · U19 · FY2006 · AI
Effects of Inhaled Florida Red Tide Brevetoxins
$1,416,710Daniel G Baden · University Of North Carolina Wilmington · P01 · FY2007 · ES
Scheduled Prophylactic 6-hourly IV Acetaminophen to Prevent Postoperative Delirium in Older Cardiac Surgical Patients
$1,416,428Balachundhar Subramaniam · Beth Israel Deaconess Medical Center · R01 · FY2021 · AG
HDL Function and Metabolism During Inflammation
$1,416,306Deneys Rem Van Der Westhuyzen · University Of Kentucky · P01 · FY2008 · HL
Biomechanics and Inflammation in Osteoarthritis
$1,416,259Duke University · P01 · FY2004 · AR
Rare variants and NHLBI traits in deeply phenotyped cohorts
$1,416,026Bruce M Psaty · University Of Washington · R01 · FY2014 · HL
Critical Analysis of the Hygiene Hypothesis
$1,415,991University Of California San Diego · P01 · FY2004 · AI
San Francisco Bay Clinical Trials Unit (CTU)
$1,415,883Susan Buchbinder · Public Health Foundation Enterprises · UM1 · FY2024 · AI